• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND CO. BD¿ POSIFLUSH¿ SALINE XS 10 ML; SALINE, VASCULAR ACCESS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND CO. BD¿ POSIFLUSH¿ SALINE XS 10 ML; SALINE, VASCULAR ACCESS FLUSH Back to Search Results
Catalog Number 306572
Device Problem Volume Accuracy Problem (1675)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/21/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported while using bd¿ posiflush¿ saline xs 10 ml the scale marking was missing on two syringes.There was no report of patient impact.The following information was provided by the initial reporter: verbatim: product: bd posiflush xs 10 ml lot number: 1203643 product expiry date: 30-jun-2024 number of defective product(s): 2 is sample available: yes unable to verify that the fluid in the syringe matches the description on the package.Syringe was lacking all appropriate markings and labelling.
 
Event Description
It was reported while using bd¿ posiflush¿ saline xs 10 ml the scale marking was missing on two syringes.There was no report of patient impact.The following information was provided by the initial reporter: verbatim: product: bd posiflush xs 10 ml.Lot number: 1203643.Product expiry date: 30-jun-2024.Number of defective product(s): 2.Is sample available: yes.Unable to verify that the fluid in the syringe matches the description on the package.Syringe was lacking all appropriate markings and labelling.
 
Manufacturer Narrative
H6: investigation: a device history record review was completed for provided material number 306572 and lot number 1203643.The review did not reveal any detected abnormalities during the production process that could have contributed to the reported defect and all quality tests were found to be within specification.As samples were not returned for this incident, a thorough sample analysis could not be completed by our quality engineer team.Based on the limited investigation results, an exact cause related to the manufacturing process could not be determined for this issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD¿ POSIFLUSH¿ SALINE XS 10 ML
Type of Device
SALINE, VASCULAR ACCESS FLUSH
Manufacturer (Section D)
BECTON, DICKINSON AND CO.
donore road
drogheda
Manufacturer (Section G)
BECTON, DICKINSON AND CO.
donore road
drogheda
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key13473157
MDR Text Key286151949
Report Number9616657-2022-00003
Device Sequence Number1
Product Code NGT
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number306572
Device Lot Number1203643
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/25/2022
Initial Date FDA Received02/07/2022
Supplement Dates Manufacturer Received02/09/2022
Supplement Dates FDA Received02/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-